Core Viewpoint - The company "未名拾光" has recently secured a B+ round financing of several tens of millions of RMB, following a previous investment of nearly 100 million RMB from L'Oréal and Naive Group, aimed at enhancing its AI technology platform and expanding its global business footprint [3][4]. Group 1: Financing and Investment - "未名拾光" has received significant investments from both L'Oréal and Naive Group, totaling nearly 100 million RMB earlier this year, and has now attracted additional funding from industrial funds [4]. - The latest financing round will primarily focus on deepening AI technology platform development and expanding the application scenarios of biological materials [3]. Group 2: Technology and Product Development - The company has established a closed-loop system for the innovation of biological materials, integrating design, screening, efficacy evaluation, and large-scale production, empowered by AI [4]. - "未名拾光" is developing two main categories of biological raw materials: plant callus tissues and bioactive proteins, including recombinant collagen and peptides [4]. - The company has created a dual-cell factory system utilizing both microbial and plant cell factories to produce various products, including rare plant active molecules [6]. Group 3: AI Integration - The team recognized the value of AI early in the development of their synthetic biology technology platform, utilizing tools like AlphaFold and RFDiffusion to enhance research efficiency [7]. - AI has significantly improved research efficiency, reportedly increasing it by at least five times, with plans to allocate 50% of R&D spending towards AI development [8]. Group 4: Business Model and Market Strategy - "未名拾光" employs a CRDMO model (CRO + CDMO) to collaborate with downstream brand partners for the development of new biological raw materials and provide contract manufacturing services [4][10]. - The company has successfully validated its model in the plant metabolite category, expanding its client base to include numerous well-known domestic and international brands [11]. Group 5: Future Directions - The company plans to expand its business in bioactive raw materials from the beauty sector to food and daily chemical applications, while also seeking international market opportunities [13].
AI加速生物活性原料创新,「未名拾光」获数千万元B+轮融资 | 早起看早期
36氪·2025-09-29 00:17